Stocktoria
Siemens Healthineers AG SHL.DE
DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website
Siemens Healthineers AG financials (annual, from 10-K)
Bars are annual figures from 2021 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $22.4B | $21.7B | $21.7B | $18.0B |
| Gross profit | $8.5B | $7.7B | $8.1B | $7.0B |
| R&D expense | $1.9B | $1.9B | $1.8B | $1.5B |
| SG&A expense | $3.7B | $3.6B | $3.4B | $2.8B |
| Operating income | $2.8B | $2.1B | $2.9B | $2.6B |
| Interest expense | $476.0M | $296.0M | $118.0M | $83.0M |
| Income tax | $564.0M | $403.0M | $746.0M | $658.0M |
| Net income | $1.9B | $1.5B | $2.0B | $1.7B |
| EPS (diluted) | $1.73 | $1.34 | $1.81 | — |
| Operating cash flow | $2.8B | $2.1B | $2.5B | $2.9B |
| Free cash flow | $2.1B | $1.3B | $1.7B | $2.3B |
| Cash & equivalents | $2.7B | $2.2B | $1.4B | $1.3B |
| Inventory | $4.1B | $4.3B | $4.0B | — |
| Total assets | $46.1B | $46.7B | $49.1B | $42.2B |
| Total liabilities | $27.8B | $28.6B | $29.2B | $25.8B |
| Shareholders' equity | $18.2B | $18.1B | $19.8B | $16.3B |
Growth · year-over-year · Revenue CAGR 7.5%
| Metric | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue growth | +3.2% | -0.2% | +20.7% | — |
| Net income growth | +28.7% | -26.0% | +18.0% | — |
| EPS growth | +29.1% | -26.0% | — | — |
| Free cash flow growth | +66.3% | -22.5% | -26.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · DE · as of 2024-09-30. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.